Main > ONCOLOGY (**) > Lymphoma>HL>Classical>Stage 3/4>+ > TREAT.: > Co: USA. S. BrentuxiMAb Vedotin>+ > (*) EU Approval Date: 2019. 02.11.

---

(*) EU Approval Date: 2019. 02.11.'s products
This section has no products